Drug-maker Valeant eyes small and large M&A deals
(Reuters) - Canada's Valeant Pharmaceuticals International Inc (VRX.TO) said on Thursday that it sees small, cash-based acquisitions likely in the near term, but is also interested in a "merger of equals" involving a swap of equity.
Chief Executive Michael Pearson said he thinks such a merger will happen, but is unsure of the timing.
(Reporting by Rod Nickel in Winnipeg, Manitoba; Editing by Gerald E. McCormick)
NUSA DUA, Indonesia - The World Trade Organization reached its first ever trade reform deal on Saturday to the roar of approval from nearly 160 ministers who had gathered on the Indonesian island of Bali to decide on the make-or-break agreement that could add $1 trillion to the global economy
SAN FRANCISCO - At Pinterest, the four-year-old online bulletin board service that is valued near $3.8 billion, some 70 percent of the users are female. But the company's board of directors is 100 percent male. | Video
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.